LMG
0.014
40%
OVT
0.001
-50%
ARO
0.004
33.3%
IBR
0.024
-46.7%
NH3
0.125
31.6%
BRY
0.013
-31.6%
SLB
0.32
25.5%
INF
0.006
-25%
BLU
0.005
25%
SPQ
0.003
-25%
BNL
0.005
25%
BGE
0.01
-23.1%
GLL
0.005
25%
AM3
0.004
-20%
GTE
0.01
25%
MHC
0.02
-20%
LIB
0.005
25%
RPM
0.012
-20%
SRJ
0.005
25%
DWG
0.125
-16.7%
CYB
0.051
21.4%
EXT
0.005
-16.7%
ECS
0.006
20%
H3E
0.005
-16.7%
PL9
0.006
20%
MX1
0.015
-16.7%
PNT
0.006
20%
KOB
0.028
-15.2%
RCL
0.06
20%
ADN
0.006
-14.3%
PLC
0.007
16.7%
AVW
0.006
-14.3%
SBR
0.007
16.7%
AX8
0.006
-14.3%
HMG
0.25
16.3%
NS1
0.006
-14.3%
IVZ
0.072
14.3%
XST
0.012
-14.3%
SCX
0.28
14.3%
IMC
0.044
-13.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Curvebeam AI (ASX:CVB): Developing enhancements to the HiRise™ platform

Curvebeam AI (ASX:CVB) is building artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. The current focus of management is to support its U.S. growth strategy and further its Stryker partnership | Investor presentation: https://wcsecure.weblink.com.au/pdf/CVB/02800840.pdf